The Bull Rankings scorecard — our quality-growth score is 69.3 / 100, built from three pillars each graded 0–100 against sector peers: Quality 54, Growth 89, Value 69. At today's price, our reverse-DCF read says the market is implicitly betting on about -2% a year in free-cash-flow growth sustained for a decade — a gauge of how much optimism is already in the stock.
The thesis
Amcor’s growth engine is humming. In the quarter ended 2026-06-30, revenue surged 56.6% year over year, a figure so outsized it demands a closer look. The market, however, is treating this as a one-off spike rather than a repeatable trend, pricing in a reverse-DCF implied free-cash-flow decline of about -2% per year for a decade. Our model’s quality-growth score of 69.3/100—with Growth at 89 and Quality at 54—suggests the market is ignoring the durability of the upturn. The PEG ratio of 1.05 tells a similar story: the multiple is high, but not absurd, if the growth is real. The stock sits 8.7% below its 52-week high and 11.6% above its low, leaving little margin for error. The bull case hinges on whether this revenue burst is the start of a new cycle or a temporary surge that will fade under the weight of its own scale.
What the business actually is
Amcor doesn’t just make boxes. It prints, molds, and laminates packaging for nutrition, health, beauty, and wellness across four continents. The Global Flexible Packaging Solutions segment is the revenue engine, supplying polymer resin, aluminum, and fiber-based flexible packaging—think squeeze tubes for sunscreen, laminated pouches for snacks, and barrier films for pharmaceuticals. The company’s product list reads like a catalog of modern consumer essentials: bottles, vials, jars, lids, trays, and even applicators for beauty products. When Ocean Potion partners with Amcor to create a ripple-effect tube for sunscreen, it’s not a side project; it’s a showcase of the segment’s design and printing capabilities. This is a business built on precision, not scale alone.
Why it can (or can't) keep compounding
The moat is in the details. A 9.4% return on equity in the latest quarter shows capital is working, but the real advantage is in the segment’s ability to lock in customers with proprietary structures. Flexible packaging isn’t a commodity when the printing process, material science, and end-market compliance matter as much as the container itself. Competitors can buy machines, but replicating Amcor’s decades of relationships with global brands in nutrition, health, and beauty takes time. The model’s Growth pillar at 89 signals the market sees this edge, but the Quality pillar at 54 warns that margins are still thin—4.7% profit margin—and debt levels are elevated, with a debt-to-equity ratio of 1.28. The question isn’t whether Amcor can grow, but whether it can grow profitably while servicing that leverage.
The valuation question
The market is pricing in a bet that Amcor’s growth will stall. A PE of 19.1 isn’t cheap, but it’s not punitive for a growth stock—especially when free cash flow for the trailing twelve months sits at $1.2 billion. The reverse-DCF, though, is the killer. A -2% annual free-cash-flow decline for a decade baked into today’s price assumes the revenue surge is a mirage. That’s a heavy lift for a company that just posted 56.6% growth. The analyst consensus splits the difference, with a 12-analyst mean target of $50.18 and a range from $42 to $60. The stock’s 52-week range—$36.25 to $50.94—tells the same story: the market is undecided, and the price is stuck in the middle.
The bear case
The weakest pillar in our model is Quality, and the numbers back it up. A debt-to-equity ratio of 1.28 isn’t a death knell, but it limits financial flexibility in a rising-rate world. The 4.7% profit margin is thin for a company of this scale, and if growth slows even modestly, that margin could compress further. The bear case argues that Amcor’s recent revenue spike is a function of post-pandemic restocking and one-off demand, not a structural shift. If that’s true, the reverse-DCF implied -2% free-cash-flow decline starts to look optimistic, not pessimistic.
What would change our mind
Three things would flip the thesis. First, if the debt-to-equity ratio drops below 1.0 in the next quarterly report, the Quality pillar would strengthen enough to justify the current multiple. Second, if the profit margin climbs above 5.5%, it would signal that the growth is translating into real earnings power, not just top-line bloat. Finally, if the revenue growth rate stabilizes above 8% annually—not the 56.6% surge, but a sustainable clip—the reverse-DCF implied -2% free-cash-flow decline would look like a mispricing, not a fair bet. Until then, the stock is a growth story priced for disappointment.